Drug name - Upneeq
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8357714 | RVL PHARMS | Compositions and methods for non-surgical treatment of ptosis |
Aug, 2031
(8 years from now) | |
| US9867808 | RVL PHARMS | Compositions and methods for non-surgical treatment of Ptosis |
Aug, 2031
(8 years from now) | |
| US10912765 | RVL PHARMS | Compositions and methods for non-surgical treatment of ptosis |
Aug, 2031
(8 years from now) | |
| US10799481 | RVL PHARMS | Compositions and methods for treating ocular disorders |
Dec, 2039
(17 years from now) | |
| US11103482 | RVL PHARMS | Oxymetazoline compositions |
Dec, 2039
(17 years from now) | |
| US10814001 | RVL PHARMS | Oxymetazoline compositions |
Dec, 2039
(17 years from now) | |
| US10898573 | RVL PHARMS | Oxymetazoline compositions |
Dec, 2039
(17 years from now) | |
| US10940138 | RVL PHARMS | Compositions and methods for treating ocular disorders |
Dec, 2039
(17 years from now) | |
Drugs and Companies using OXYMETAZOLINE HYDROCHLORIDE ingredient
Treatment: Method of treating blepharoptosis
Dosage: SOLUTION/DROPS;OPHTHALMIC
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.1% | SOLUTION/DROPS;OPHTHALMIC | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.